
General meeting
09:30
17:30
10:30
14:30
15:00
18:00
20:30
P.4. Accesses
Presidency: E. Efthimiou, D. Kirmizis
1. AVF dysfunction: diagnosis and treatment
Evdokia Efthymiou
2. Tenckhoff catheter insertion - Medical
Praveen Ande
3. Tenckhoff catheter insertion - Surgical
Fahed Youssef
P.5. Resolving cardio-renal-metabolic syndrome
Presidency: E. Fousteris, A. Papazafeiropoulou
Commentator: D. Vlachakos, D. Kirmizis
1. Review of the guidelines
Evangelos Fousteris
2. SGLT2 inhibitors: are they all the same?
E. Korakas
3. The central role of incretin hormones
Konstantinos Balabanis
4. Cardio-renal-metabolic syndrome from the perspective of the Nephrologist
Panagiotis Nennes
Sunday, September 15
Challenges and prospects in Nephrology

P.3. Hypertension
Presidency: D. Vlachakos, A. Zagorianakos
Commentators: E. Intzevidou, G. Hadjivasiliou
1. Hypertension in CKD: Evaluation and treatment
Dimitrios Vlachakos
2. Hypertension on dialysis
Antonios Zagorianakos
3. Posterior reversible encephalopathy syndrome
Gregory Myserlis
ERATO Hall
SAPPHORE Hall
P.6. Latest in systemic diseases
Presidency: V. Kolovos, I. Droulias
Commentator: D. Moysiadis
1. Atypical hemolytic uremic syndrome and TMA
Eleni Gavrilaki
2. Monoclonal gammopathies
Vasilios Chatziantoniou
3. Polycystic kidney disease: new developments in diagnostic and therapeutic approach
Mahel Chintana Galahitiyawa
4. Lupus nephritis: what's new
Jeff Eberhard
General meeting
P.3. Quality of services and patient safety in Hemodialysis Units
1. The experience of the British Health System
and the Greek Units
2. Presentation of the Unit evaluation system
D.3. Endovascular fistula creation systems Alexander Mallios
Break
D.4. The use of continuous glucose monitoring systems in people with diabetes: Basic concepts
Athanasia Papazafeiropoulou
P.8. Latest in the treatment of CKD
Presidency: D. Bakoulis, E. Heliotis
1. Stroke prevention in CKD
Manolis Tzambarlis
2. Calcimitics: their place in clinical practice
Dimitrios Bakoulis
3. Prevention & treatment of osteoporosis
Eleni Helioti
P.7. Newer treatments in CKD
Presidency: A. Gombou, P. Kompotiatis
Commentator: I. Droulias
1. HIF-pH inhibitors
Athena Gombou
2. Treatment of hyperkalemia
Vaia Raikou
3. Latest in iron therapy
Panagiotis Kompotiatis
4. Newer oral anticoagulants
Konstantinos Psounis
D.6. What's new in the monitoring and treatment of IgA nephropathy
Vasilios Kolovos
D.5. Treatment and outcome of heart failure in CKD
George Tzanis
D.7. Latest developments in the treatment of uremic pruritus
Olga Hellina
12:00
12:30
Expiry
Break
Break
Break
D.2. The role of renal aponeurosis in the treatment of hypertension
Kyriakos Dimitriadis
Co-organization with the organization